Sangamo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.About SGMO
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases.
CEOAlexander D. Macrae
CEOAlexander D. Macrae
Employees183
Employees183
HeadquartersRichmond, California
HeadquartersRichmond, California
Founded1995
Founded1995
Employees183
Employees183
SGMO Key Statistics
Market cap115.85M
Market cap115.85M
Price-Earnings ratio-1.23
Price-Earnings ratio-1.23
Dividend yield—
Dividend yield—
Average volume6.62M
Average volume6.62M
High today$0.4879
High today$0.4879
Low today$0.43
Low today$0.43
Open price$0.4529
Open price$0.4529
Volume6.00M
Volume6.00M
52 Week high$3.18
52 Week high$3.18
52 Week low$0.304
52 Week low$0.304
SGMO News
TipRanks 3d
Sangamo Biosciences Announces $23 Million Share OfferingProtect Your Portfolio Against Market Uncertainty Sangamo Biosciences ( (SGMO) ) has provided an update. On May 12, 2025, Sangamo Therapeutics announced an un...
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%
People also own
Based on the portfolios of people who own SGMO. This list is generated using Robinhood data, and it’s not a recommendation.